Corporate News Report – Market Activity Update
Lifecore Biomedical (LFCR)
Current Trading Session
LFCR closed 0.31 % lower at 02:14 AM CET on Thursday 22 Oct 2026.
Trading price: USD 6.37.
Share Supply and Capitalisation
Outstanding shares: 37.9 million.
Market capitalisation: USD 241.9 million.
Recent Trading Volume
Volume in the last 24 hours: USD 3.7 million.
Since the end of the previous month, the share price has increased by 42.19 %.
Technical Indicators
200‑day simple moving average: USD 5.56.
52‑week high: USD 8.98 (27 Jan 2026).
52‑week low: USD 3.63 (31 Mar 2026).
Company Profile Lifecore Biomedical, Inc. is a contract development and manufacturing organisation (CDMO) in the health‑care sector, focusing on food‑grade and pharmaceutical‑grade products. The firm supplies sterile injectable pharmaceutical products in syringes and vials, and manufactures pharmaceutical‑grade sodium hyaluronate. Lifecore operates globally and maintains a corporate website at www.lifecore.com . The company was listed on the Nasdaq stock exchange on 15 Feb 1996.
Related Stock Movements – Last 24 Hours
| Symbol | Company | 24‑hour Change | Current Price | Market Capitalisation |
|---|---|---|---|---|
| MLP | Maui Land & Pineapple | +0.83 % | USD 14.22 | USD 288.2 million |
| ARTV | Artiva Biotherapeutics | +11.38 % | USD 6.49 | USD 288.0 million |
| CMRC | Commerce | +9.20 % | USD 3.62 | USD 288.4 million |
| ADAC | American Drive Acquisit | -0.30 % | USD 10.06 | USD 289.8 million |
| ATLO | Ames National | -0.06 % | USD 32.66 | USD 286.2 million |
| (P/E ratio) | 11.28 |
These figures provide a snapshot of the short‑term performance of peer companies within the same sector.